NDAQ:ATAI - Post Discussion
Post by
AwareInvestor on Jun 18, 2021 7:54am
Atai Life Sciences Increases IPO To $225 Million
Atai Life Sciences late last night announced the pricing of its upsized initial public offering. The clinical-stage biotech firm now expects its IPO to raise gross proceeds of roughly $225.0 million for the company.
Be the first to comment on this post